Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2695 |
|
| Actual shortage: | 246 (9%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2440 (91%) | |
Discontinuation Reports |
250 |
|
| To be discontinued: | 3 (1%) | |
| Discontinued: | 247 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
26 (10%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-PROPRANOLOL | 10MG | TABLET | Resolved | 2022-06-30 | 2022-08-16 | 163903 |
| TEVA-PROPRANOLOL | 80MG | TABLET | Resolved | 2022-06-30 | 2022-08-16 | 163906 |
| TEVA-NAPROXEN | 250MG | TABLET | Resolved | 2022-06-30 | 2022-08-19 | 163909 |
| TEVA-LORAZEPAM | 1MG | TABLET | Resolved | 2022-06-30 | 2023-04-28 | 163912 |
| TEVA-LORAZEPAM | 2MG | TABLET | Resolved | 2022-06-30 | 2023-06-09 | 163915 |
| TEVA-LORAZEPAM | 0.5MG | TABLET | Resolved | 2022-06-30 | 2023-04-28 | 163918 |
| TEVA-TRAZODONE | 100MG | TABLET | Resolved | 2022-06-30 | 2023-06-27 | 163921 |
| TEVA-MEXILETINE | 100MG | CAPSULE | Resolved | 2022-06-30 | 2022-08-19 | 163924 |
| TEVA-PRAVASTATIN | 10MG | TABLET | Resolved | 2022-06-30 | 2023-04-28 | 163927 |
| TEVA-OLANZAPINE | 2.5MG | TABLET | Resolved | 2022-06-30 | 2022-08-09 | 163930 |
| TEVA-OLANZAPINE | 5MG | TABLET | Resolved | 2022-06-30 | 2022-08-20 | 163933 |
| TEVA-FENTANYL | 50MCG | PATCH | Resolved | 2022-06-30 | 2022-08-09 | 163936 |
| TEVA-FENTANYL | 100MCG | PATCH | Resolved | 2022-06-30 | 2022-09-23 | 163939 |
| TEVA-OMEPRAZOLE | 10MG | TABLET (DELAYED-RELEASE) | Resolved | 2022-06-30 | 2023-04-28 | 163942 |
| TEVA-OMEPRAZOLE | 20MG | TABLET (DELAYED-RELEASE) | Resolved | 2022-06-30 | 2023-04-28 | 163945 |
| TEVA-RISEDRONATE | 5MG | TABLET | Resolved | 2022-06-30 | 2022-12-08 | 163948 |
| TEVA-MONTELUKAST | 5MG | TABLET (CHEWABLE) | Resolved | 2022-06-30 | 2022-10-18 | 163951 |
| TEVA-OLANZAPINE | 20MG | TABLET | Resolved | 2022-06-30 | 2022-10-18 | 163954 |
| TEVA-RISEDRONATE | 150MG | TABLET | Resolved | 2022-06-30 | 2024-02-06 | 163957 |
| ACT LEVOFLOXACIN | 500MG | TABLET | Resolved | 2022-07-25 | 2023-04-28 | 165430 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-ROSUVASTATIN | 40MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157437 |
| PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.375G 3G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210191 |
| PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.5G 4G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210194 |
| CEFAZOLIN FOR INJECTION | 10G | POWDER FOR SOLUTION | Discontinued | 2023-11-27 | 2023-11-27 | 211558 |
| TEVA-ECTOSONE | 0.1% | LOTION | Discontinued | 2023-12-05 | 2023-12-05 | 212526 |
| TEVA-DICLOFENAC EC | 25MG | TABLET (ENTERIC-COATED) | Discontinued | 2024-01-25 | 2024-01-26 | 217254 |
| TEVA-IRBESARTAN | 75MG | TABLET | Discontinued | 2024-04-01 | 2024-04-01 | 224049 |
| VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | To be discontinued | 2019-07-05 | 2019-07-05 | 88619 |
| ACT CELECOXIB | 100MG | CAPSULE | To be discontinued | 2020-09-03 | 2020-09-03 | 123648 |
| ACT CELECOXIB | 200MG | CAPSULE | To be discontinued | 2020-09-03 | 2020-09-03 | 123651 |